Healthstream (HSTM) FY2017 results: revenue $215 million, up 11.9% on the year
Healthstream Inc. (HSTM) reported revenue of $215 million for fiscal 2017, the year ended 31 December 2017, up 11.9% on the year before. Net income was $10 million, up 166.4%, and diluted earnings per share $0.31. The figures are the company's own, from the 10-K it filed with the SEC on 25 February 2019.
Revenue
$215 million
+11.9% on the year
FY2010FY2017
Operating margin
4.4%
3.7% a year earlier
FY2010FY2017
Net income
$10 million
+166.4% on the year
FY2010FY2017
Diluted EPS
$0.31
+158.3% on the year
FY2010FY2017
this yearthe year beforeHover a bar for its figure.
The year in brief
Income statement (profit and loss)
$ million
FY2017
FY2016
FY2015
On the year
Last 8 years
Revenue
215
192
209
+11.9%
Cost of revenue
87.2
n/a
n/a
Gross profit
128
n/a
n/a
Gross margin
59.4%
n/a
n/a
Research and development
24.1
24.2
24.2
-0.4%
Operating income
9.4
7.2
13.6
+31.2%
Operating margin
4.4%
3.7%
6.5%
Pre-tax income
10.1
7.8
13.7
+30.8%
Income tax
1.3
3.0
5.1
-56.0%
Effective tax rate
12.8%
38.2%
37.2%
Net income
10.0
3.8
8.6
+166.4%
Net margin
4.7%
2.0%
4.1%
Diluted EPS
$0.31
$0.12
$0.28
+158.3%
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2017
FY2016
FY2015
On the year
Last 8 years
Operating cash flow
46.7
24.2
34.9
+92.8%
Capital expenditure
5.5
4.8
8.1
+14.8%
Free cash flow
41.2
19.4
26.8
+112.0%
Free cash flow margin
19.2%
10.1%
12.8%
Cash from investing
-11.6
-56.7
n/a
Cash from financing
0.0
0.0
n/a
-97.8%
Depreciation and amortisation
24.0
20.4
17.0
+18.1%
Share-based compensation
1.7
1.9
3.3
-8.4%
Diluted shares, weighted
32m
32m
30m
+0.4%
Shares outstanding at period end
32m
32m
32m
+0.5%
Balance sheet
$ million
FY2017
FY2016
FY2015
On the year
Last 8 years
Shareholders' equity
300
286
280
+4.9%
Debt
0.0
0.0
0.0
Other liabilities
111
110
99.2
+0.9%
Total liabilities and equity
411
396
380
+3.8%
Fixed assets
8.1
10.2
12.5
-21.0%
Goodwill
86.1
85.6
83.1
+0.6%
Intangible assets
68.5
78.4
56.0
-12.6%
Investments
46.4
53.5
67.0
-13.4%
Cash and equivalents
84.8
49.6
82.0
+70.8%
Receivables
36.7
44.8
36.3
-18.1%
Other assets
80.5
73.8
42.7
+9.1%
Total assets
411
396
380
+3.8%
10-K for the year ended 31 December 2017, filed 25 February 2019: the filing.